Neuromuscular monitoring and neuromuscular blocking agent shortages when treating critically ill COVID-19 patients: a multicentre retrospective analysis

Br J Anaesth. 2021 Aug;127(2):e73-e75. doi: 10.1016/j.bja.2021.04.028. Epub 2021 May 14.
No abstract available

Keywords: COVID-19; cisatracurium; mechanical ventilation; neuromuscular blocking agent; train-of-four monitoring.

Publication types

  • Letter
  • Comment

MeSH terms

  • Atracurium
  • COVID-19*
  • Critical Illness
  • Humans
  • Neuromuscular Blocking Agents*
  • Neuromuscular Monitoring
  • Retrospective Studies
  • SARS-CoV-2

Substances

  • Neuromuscular Blocking Agents
  • Atracurium